Matthew William Leckenby

Title: Matthew William Leckenby: Innovator in Genetic Engineering

Introduction

Matthew William Leckenby is a notable inventor based in Peseux, Switzerland. He has made significant contributions to the field of genetic engineering, particularly through his innovative work on plasmids. His research focuses on developing methods that enhance the efficiency and safety of genetic modifications.

Latest Patents

Leckenby holds a patent for a "Self-deleting plasmid." This invention describes a method of producing a selectable marker gene-free plasmid by culturing a plasmid containing a selectable marker gene flanked by site-specific recombinase target sites in a host cell environment incapable of effecting recombination. The process involves subsequently culturing the plasmid in another host cell environment capable of effecting recombination, leading to the excision of the selectable marker gene. The plasmids produced by this method have various applications, including the production of recombinant proteins for therapeutic and vaccine purposes, the production of therapeutic DNA and DNA vaccines, and the delivery of recombinant proteins and DNA to patients using live bacterial vectors.

Career Highlights

Leckenby is currently associated with Cobra Biologics Limited, where he continues to advance his research in biotechnology. His work has been instrumental in developing innovative solutions that address challenges in genetic engineering and therapeutic applications.

Collaborations

Leckenby collaborates with various professionals in the field, including his coworker Rocky Marc Cranenburgh. Their combined expertise contributes to the ongoing advancements in genetic research and development.

Conclusion

Matthew William Leckenby is a pioneering inventor whose work in genetic engineering has the potential to revolutionize therapeutic applications. His innovative approach to plasmid technology exemplifies the importance of research in advancing medical science.